Gersten D M, Hearing V J
Department of Pathology, Georgetown University Medical Center, Washington, D.C. 20007.
Pigment Cell Res. 1988;1(6):434-8. doi: 10.1111/j.1600-0749.1988.tb00147.x.
B700 is a melanoma-associated antigen originally detected by immunologic and biochemical criteria; it is expressed by several murine melanomas but is not detectable on any normal murine cells, or on murine nonmelanoma neoplasms. We have used antibodies raised against purified B700 to study the presentation of B700 and B700 crossreactive molecules on the surfaces of melanoma cells of various species and origins. The antibodies are shown to bind to all the melanoma cells tested, including five different murine melanoma lines (S91, JB/RH, JB/MS, K1735, and B16), three different B16 sublines (F1, F10, and BL6), three human, one hamster, and two swine melanoma cell lines. These results suggest the candidacy of B700-like molecules as "pan-melanoma" antigens.
B700是一种最初通过免疫学和生化标准检测到的黑色素瘤相关抗原;它由几种小鼠黑色素瘤表达,但在任何正常小鼠细胞或小鼠非黑色素瘤肿瘤上均检测不到。我们使用针对纯化的B700产生的抗体来研究B700和B700交叉反应分子在各种物种和来源的黑色素瘤细胞表面的呈现。结果表明,这些抗体可与所有测试的黑色素瘤细胞结合,包括五种不同的小鼠黑色素瘤细胞系(S91、JB/RH、JB/MS、K1735和B16)、三种不同的B16亚系(F1、F10和BL6)、三种人类、一种仓鼠和两种猪黑色素瘤细胞系。这些结果表明B700样分子作为“泛黑色素瘤”抗原的可能性。